Laura J. Schumacher, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 7,400 shares at $48.02 ($355K) on 2011-02-28, disclosed to the SEC on 2011-03-02.
Scheduled sale ($355k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.00 | 800 | $38K | 10.8% |
| 2 | $48.00 | 100 | $5K | 1.4% |
| 3 | $48.00 | 600 | $29K | 8.1% |
| 4 | $48.01 | 100 | $5K | 1.4% |
| 5 | $48.01 | 600 | $29K | 8.1% |
| 6 | $48.02 | 400 |
| $19K |
| 5.4% |
| 7 | $48.02 | 100 | $5K | 1.4% |
| 8 | $48.03 | 300 | $14K | 4.1% |
| 9 | $48.03 | 800 | $38K | 10.8% |
| 10 | $48.04 | 500 | $24K | 6.8% |
| 11 | $48.05 | 800 | $38K | 10.8% |
| 12 | $48.06 | 1,000 | $48K | 13.5% |
| 13 | $48.06 | 500 | $24K | 6.8% |
| 14 | $48.07 | 600 | $29K | 8.1% |
| 15 | $48.07 | 200 | $10K | 2.7% |
| Total | $48.03 avg | 7,400 | $355K | 100% |
| Filing → |
| ABBV | BUY | 2019-09-18 | $1.8M | — | Filing → |
| ABBV | SELL | 2019-03-15 | $2.0M | — | Filing → |
| ABBV | SELL | 2019-01-02 | $2.3M | — | Filing → |